Atlas Trials

Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma

Clinical trial NCT01446562 · COMPLETED

Trial details

NCT number
NCT01446562
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Follicular Lymphoma
Start date
2007-05-01
Primary completion
2016-05-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.